
Paris-based Aqemia picks up €30 million capital injection to uncover breakthrough drug discoveries at scale
Published on October 19, 2022
Pharmatech startup Aqemia has just raised €30 million in a new funding round. The Parisian startup is generating a pioneering drug discovery pipeline that aims to design fast drugs for critical diseases through an AI-powered process that allows drug discovery projects to be scaled like tech projects. One of the core challenges in western medicine…
The post Paris-based Aqemia picks up €30 million capital injection to uncover breakthrough drug discoveries at scale appeared first on EU-Startups.
